Inter Pharma PCL (BKK:IP)

Thailand · Delayed Price · Currency is THB

4.460

+0.080 (1.83%)

Jun 17, 2026, 10:22 AM ICT

42.95% (1Y)

Market Cap	2.65B +22.3%
Revenue (ttm)	2.24B +14.5%
Net Income	132.64M +186.0%
EPS	0.22 +186.0%
Shares Out	605.34M
PE Ratio	19.99
Forward PE	n/a
Dividend	0.07 (1.64%)
Ex-Dividend Date	May 6, 2026

Volume	101,212
Open	4.380
Previous Close	4.380
Day's Range	4.380 - 4.460
52-Week Range	2.980 - 4.700
Beta	0.42
Analysts	Hold
Price Target	10.46 (+134.53%)
Earnings Date	Aug 11, 2026

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2006

Country Thailand

Stock Exchange Stock Exchange of Thailand

Ticker Symbol IP

Full Company Profile

Financial Performance

In 2025, Inter Pharma PCL's revenue was 2.21 billion, an increase of 15.80% compared to the previous year's 1.91 billion. Earnings were 122.38 million, an increase of 233.93%.

Financial Statements